Evidence map›Paper›PMID 37829723›Full record

ArticleFrontiers in neuroscience2023

Isolation of the murine Glut1 deficient thalamocortical circuit: wavelet characterization and reverse glucose dependence of low and gamma frequency oscillations.

Elysandra M Solis, Levi B Good, Rafael Granja Vázquez, Sourav Patnaik, Ana G Hernandez-Reynoso, Qian Ma, Gustavo Angulo, Aksharkumar Dobariya, Stuart F Cogan, Joseph J Pancrazio and 2 more

Abstract read
In one paragraph

Article in Frontiers in neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Elysandra M SolisDepartment of Bioengineering, The University of Texas at Dallas, Richardson, TX, United States.
Levi B GoodDepartment of Bioengineering, The University of Texas at Dallas, Richardson, TX, United States.
Rafael Granja VázquezDepartment of Neuroscience and the Center for Advanced Pain Studies, The University of Texas Southwestern Medical Center, Dallas, TX, United States.
Sourav PatnaikDepartment of Bioengineering, The University of Texas at Dallas, Richardson, TX, United States.
Ana G Hernandez-ReynosoDepartment of Bioengineering, The University of Texas at Dallas, Richardson, TX, United States.
Qian MaRare Brain Disorders Program, The University of Texas Southwestern Medical Center, Dallas, TX, United States.
Gustavo AnguloRare Brain Disorders Program, The University of Texas Southwestern Medical Center, Dallas, TX, United States.
Aksharkumar DobariyaRare Brain Disorders Program, The University of Texas Southwestern Medical Center, Dallas, TX, United States.
Stuart F CoganDepartment of Bioengineering, The University of Texas at Dallas, Richardson, TX, United States.
Joseph J PancrazioDepartment of Bioengineering, The University of Texas at Dallas, Richardson, TX, United States.
Juan M PascualRare Brain Disorders Program, The University of Texas Southwestern Medical Center, Dallas, TX, United States.
Vikram JakkamsettiRare Brain Disorders Program, The University of Texas Southwestern Medical Center, Dallas, TX, United States.

Funding

Brain Glucose Deficiency: Mechanisms and ModulationRM1NS133593 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI Joseph J. Pancrazio, Juan M. Pascual · 2023 to 2026
$5.3M
Pyruvate dehydrogenase encephalopathy: mechanisms and therapyR01NS102588 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI PASCUAL, JUAN M. · 2017 to 2021
$1.8M
Modulation of neural function in energy failureR01NS077015 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI PASCUAL, JUAN M. · 2012 to 2016
$1.7M
Mechanisms of motor superperformanceR56NS121993 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI PASCUAL, JUAN M. · 2022 to 2022
$540k
NINDS NIH HHS R01 NS077015NINDS NIH HHS R01 NS102588NINDS NIH HHS R56 NS121993NINDS NIH HHS RM1 NS133593
6 · The paper itself

Abstract

Glucose represents the principal brain energy source. Thus, not unexpectedly, genetic glucose transporter 1 (Glut1) deficiency (G1D) manifests with encephalopathy. G1D seizures, which constitute a prominent disease manifestation, often prove refractory to medications but may respond to therapeutic diets. These seizures are associated with aberrant thalamocortical oscillations as inferred from human electroencephalography and functional imaging. Mouse electrophysiological recordings indicate that inhibitory neuron failure in thalamus and cortex underlies these abnormalities. This provides the motivation to develop a neural circuit testbed to characterize the mechanisms of thalamocortical synchronization and the effects of known or novel interventions. To this end, we used mouse thalamocortical slices on multielectrode arrays and characterized spontaneous low frequency oscillations and less frequent 30-50 Hz or gamma oscillations under near-physiological bath glucose concentration. Using the cortical recordings from layer IV among other regions recorded, we quantified oscillation epochs

Indexed as

glucose transporterGlut1metabolismmultielectrode arrayoscillationsthalamus

Identifiers

PMID37829723
PMCPMC10565352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.